Fact CheckerSign in

NCT06839755Recruiting

The Positive Prognostic Value of Stress Echocardiography - AMPHIPOLIS STUDY

The Prognostic Value of Positive Stress Echocardiography and Its Relationship with Invasive Coronary Angiography: the AMPHIPOLIS Study

Source: ClinicalTrials.gov · Last updated 21 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a prospective, multicenter, observational study of patients with recent stress echocardiography positive for myocardial ischemia. Up to now 25 echocardiography labs form Greece and Cyprus have declared their intention to participate. The investigators will enroll 390 patients with a positive stress echo, who will undergo invasive coronary angiogram and then will be followed up for at least 6 months. The objectives are the following: 1. To assess the prognostic value of positive stress echo by monitoring for cardiovascular death and major adverse cardiovascular events (MACE) during the follow-up. 2. To investigate the relationship of stress echo findings with invasive coronary angiography anatomical findings. 3. The association of cardiovascular risk profile of participants with stress echo and coronary angiography findings.

Status (registry)
Recruiting
Study type
Observational
Enrollment
390 (estimated)
First submitted
4 Feb 2025
Start date
1 Oct 2024
Primary completion date
31 Jan 2027
Lead sponsor
Hellenic Society of Cardiology
NCT number
NCT06839755

What you commit to

  • Study type: Observational
  • Planned participants: 390
  • From 1 Oct 2024 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc).

Other illness

  • Any symptomatic valvular disease causing symptoms.
  • Recent acute coronary syndrome the last week.

Other

  • HFrEF requiring viability study.
  • Established or suspected cardiomyopathy.

Who the study is looking for

  • Patients with recent stress echocardiography positive for any extent of myocardial ischemia

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hellenic Society of Cardiology
Coordinator of this site? Confirm its status
AthensGreeceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.